Viewing Study NCT02925104


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-04 @ 12:53 PM
Study NCT ID: NCT02925104
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2016-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.
Sponsor: Novartis Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-12-14
Start Date Type: ACTUAL
Primary Completion Date: 2018-05-16
Primary Completion Date Type: ACTUAL
Completion Date: 2018-05-16
Completion Date Type: ACTUAL
First Submit Date: 2016-10-04
First Submit QC Date: None
Study First Post Date: 2016-10-05
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-12-16
Last Update Post Date: 2020-12-19
Last Update Post Date Type: ACTUAL